United Therapeutics (UTHR) is up 34.6%, or $105.59 to $410.35.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UTHR:
- United Therapeutics price target raised to $463 from $314 at BofA
- Promising Developments in United Therapeutics’ Tyvaso Drive Buy Rating Amidst IPF Treatment Advancements
- United Therapeutics price target raised to $564 from $432 at Jefferies
- United Therapeutics rises 42.1%
- United Therapeutics Stock (UTHR) Rockets 40% on Clinical Trial Results